Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury - PubMed (original) (raw)

Review

Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury

Michele Curcio et al. Prog Neurobiol. 2016 Aug.

Abstract

The excessive extracellular accumulation of glutamate in the ischemic brain leads to an overactivation of glutamate receptors with consequent excitotoxic neuronal death. Neuronal demise is largely due to a sustained activation of NMDA receptors for glutamate, with a consequent increase in the intracellular Ca(2+) concentration and activation of calcium- dependent mechanisms. Calpains are a group of Ca(2+)-dependent proteases that truncate specific proteins, and some of the cleavage products remain in the cell, although with a distinct function. Numerous studies have shown pre- and post-synaptic effects of calpains on glutamatergic and GABAergic synapses, targeting membrane- associated proteins as well as intracellular proteins. The resulting changes in the presynaptic proteome alter neurotransmitter release, while the cleavage of postsynaptic proteins affects directly or indirectly the activity of neurotransmitter receptors and downstream mechanisms. These alterations also disturb the balance between excitatory and inhibitory neurotransmission in the brain, with an impact in neuronal demise. In this review we discuss the evidence pointing to a role for calpains in the dysregulation of excitatory and inhibitory synapses in brain ischemia, at the pre- and post-synaptic levels, as well as the functional consequences. Although targeting calpain-dependent mechanisms may constitute a good therapeutic approach for stroke, specific strategies should be developed to avoid non-specific effects given the important regulatory role played by these proteases under normal physiological conditions.

Keywords: Brain ischemia; Calpain; GABAergic synapses; Glutamatergic synapses; Neuronal death; Scaffold proteins.

PubMed Disclaimer

Cited by

Mitochondrial Calcium Uniporter (MCU) is Involved in an Ischemic Postconditioning Effect Against Ischemic Reperfusion Brain Injury in Mice.
Sasaki H, Nakagawa I, Furuta T, Yokoyama S, Morisaki Y, Saito Y, Nakase H. Sasaki H, et al. Cell Mol Neurobiol. 2024 Apr 3;44(1):32. doi: 10.1007/s10571-024-01464-7. Cell Mol Neurobiol. 2024. PMID: 38568450 Free PMC article.
Electroacupuncture Pretreatment Elicits Tolerance to Cerebral Ischemia/Reperfusion through Inhibition of the GluN2B/m-Calpain/p38 MAPK Proapoptotic Pathway.
Zhang BY, Wang GR, Ning WH, Liu J, Yang S, Shen Y, Wang Y, Zhao MX, Li L. Zhang BY, et al. Neural Plast. 2020 Sep 29;2020:8840675. doi: 10.1155/2020/8840675. eCollection 2020. Neural Plast. 2020. PMID: 33061951 Free PMC article.
Biallelic variants in the calpain regulatory subunit CAPNS1 cause pulmonary arterial hypertension.
Postma AV, Rapp CK, Knoflach K, Volk AE, Lemke JR, Ackermann M, Regamey N, Latzin P, Celant L, Jansen SMA, Bogaard HJ, Ilgun A, Alders M, van Spaendonck-Zwarts KY, Jonigk D, Klein C, Gräf S, Kubisch C, Houweling AC, Griese M. Postma AV, et al. Genet Med Open. 2023;1(1):100811. doi: 10.1016/j.gimo.2023.100811. Genet Med Open. 2023. PMID: 38230350 Free PMC article.
Silencing of microRNA-494 inhibits the neurotoxic Th1 shift via regulating HDAC2-STAT4 cascade in ischaemic stroke.
Zhao H, Li G, Wang R, Tao Z, Ma Q, Zhang S, Han Z, Yan F, Li F, Liu P, Ma S, Ji X, Luo Y. Zhao H, et al. Br J Pharmacol. 2020 Jan;177(1):128-144. doi: 10.1111/bph.14852. Epub 2019 Nov 8. Br J Pharmacol. 2020. PMID: 31465536 Free PMC article.
Inherited Retinal Degeneration: PARP-Dependent Activation of Calpain Requires CNG Channel Activity.
Yan J, Günter A, Das S, Mühlfriedel R, Michalakis S, Jiao K, Seeliger MW, Paquet-Durand F. Yan J, et al. Biomolecules. 2022 Mar 15;12(3):455. doi: 10.3390/biom12030455. Biomolecules. 2022. PMID: 35327647 Free PMC article.

Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury - PubMed (original) (raw)